Characterizing the Mechanism of Doxorubicin Mediated SAT1 Induction in Triple-Negative Breast Cancer

被引:0
|
作者
White, Chloe [1 ]
Liang, Caroline [1 ]
Velenosi, Thomas [1 ]
机构
[1] Univ British Columbia, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:37
相关论文
共 50 条
  • [31] Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer
    Hu, Chuling
    Liu, Yan
    Cao, Wei
    Li, Na
    Gao, Shen
    Wang, Zhuo
    Gu, Fenfen
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 507 - 526
  • [32] Elucidating the Anticancer Mechanism of Arachidin-1 in Triple-Negative Breast Cancer Cells
    Weaver, Alexx P.
    Mohammadhosseinpour, Sepideh
    Medina-Bolivar, Fabricio
    FASEB JOURNAL, 2022, 36
  • [33] Theranostics for Triple-Negative Breast Cancer
    Choi, Hyeryeon
    Kim, Kwangsoon
    DIAGNOSTICS, 2023, 13 (02)
  • [34] Advanced Triple-Negative Breast Cancer
    Patel, Grisma
    Prince, Alison
    Harries, Mark
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [35] What is triple-negative breast cancer?
    Irvin, William J., Jr.
    Carey, Lisa A.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2799 - 2805
  • [36] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01): : 59 - 66
  • [37] Pembrolizumab in Triple-Negative Breast Cancer
    Altundag, Kadri
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15): : 1435 - 1436
  • [38] A Review of Triple-Negative Breast Cancer
    Ismail-Khan, Roohi
    Bui, Marilyn M.
    CANCER CONTROL, 2010, 17 (03) : 173 - 176
  • [39] Triple-negative breast cancer: an update
    Boolbol, Susan K.
    Cate, Sarah P.
    BREAST CANCER MANAGEMENT, 2014, 3 (02) : 127 - 129
  • [40] Morphotypes of the triple-negative breast cancer
    Koleckova, M.
    Kolar, Z.
    Ehrmann, J.
    Korinkova, G.
    Trojanec, R.
    VIRCHOWS ARCHIV, 2017, 471 : S296 - S296